Viewing Study NCT00390156


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-04-11 @ 5:35 PM
Study NCT ID: NCT00390156
Status: COMPLETED
Last Update Posted: 2020-07-28
First Post: 2006-10-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib, Bevacizumab, and Cyclophosphamide in Patients With Refractory Metastatic Solid Tumors
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unspecified Adult Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory View
None prior treatment View
None solid tumors View
None phase I View
None phase 1 View